End-of-day quote
Taipei Exchange
03:30:00 10/05/2024 am IST
|
5-day change
|
1st Jan Change
|
21.1
TWD
|
+6.57%
|
|
+5.24%
|
+106.86%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
1,994
|
6,058
|
1,607
|
1,553
|
1,276
|
1,502
|
Enterprise Value (EV)
1 |
1,946
|
6,547
|
2,097
|
1,579
|
1,311
|
1,543
|
P/E ratio
|
-6.61
x
|
-38
x
|
-4.5
x
|
-5.17
x
|
-5.03
x
|
7.23
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
2.47
x
|
4.9
x
|
1.44
x
|
1.73
x
|
1.55
x
|
1.78
x
|
EV / Revenue
|
2.41
x
|
5.3
x
|
1.88
x
|
1.76
x
|
1.59
x
|
1.82
x
|
EV / EBITDA
|
-23.1
x
|
-151
x
|
-5.89
x
|
-12
x
|
-17.3
x
|
160
x
|
EV / FCF
|
-11.6
x
|
-216
x
|
42.5
x
|
-10.9
x
|
1,340
x
|
-7.57
x
|
FCF Yield
|
-8.65%
|
-0.46%
|
2.35%
|
-9.21%
|
0.07%
|
-13.2%
|
Price to Book
|
1.98
x
|
7.01
x
|
2.93
x
|
1.65
x
|
1.85
x
|
1.56
x
|
Nbr of stocks (in thousands)
|
85,863
|
86,382
|
87,002
|
1,47,218
|
1,47,218
|
1,47,218
|
Reference price
2 |
23.22
|
70.13
|
18.48
|
10.55
|
8.670
|
10.20
|
Announcement Date
|
30/04/19
|
30/04/20
|
29/04/21
|
29/04/22
|
02/05/23
|
30/04/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
807.5
|
1,236
|
1,114
|
898.1
|
825.4
|
845.7
|
EBITDA
1 |
-84.4
|
-43.47
|
-355.8
|
-131.6
|
-75.58
|
9.62
|
EBIT
1 |
-199.1
|
-155.9
|
-480.5
|
-258.7
|
-190.7
|
-117
|
Operating Margin
|
-24.66%
|
-12.61%
|
-43.15%
|
-28.81%
|
-23.11%
|
-13.84%
|
Earnings before Tax (EBT)
1 |
-265.4
|
-180.5
|
-529.1
|
-293.2
|
-253.6
|
209.2
|
Net income
1 |
-265.4
|
-158.9
|
-354.8
|
-293.2
|
-253.6
|
207.7
|
Net margin
|
-32.87%
|
-12.86%
|
-31.86%
|
-32.65%
|
-30.73%
|
24.56%
|
EPS
2 |
-3.513
|
-1.847
|
-4.103
|
-2.040
|
-1.723
|
1.410
|
Free Cash Flow
1 |
-168.4
|
-30.24
|
49.3
|
-145.4
|
0.9782
|
-203.8
|
FCF margin
|
-20.86%
|
-2.45%
|
4.43%
|
-16.18%
|
0.12%
|
-24.1%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
30/04/19
|
30/04/20
|
29/04/21
|
29/04/22
|
02/05/23
|
30/04/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
489
|
490
|
25.7
|
34.2
|
41
|
Net Cash position
1 |
47.2
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-11.26
x
|
-1.377
x
|
-0.195
x
|
-0.4529
x
|
4.264
x
|
Free Cash Flow
1 |
-168
|
-30.2
|
49.3
|
-145
|
0.98
|
-204
|
ROE (net income / shareholders' equity)
|
-31.7%
|
-19.4%
|
-75.1%
|
-39.4%
|
-31.1%
|
25.2%
|
ROA (Net income/ Total Assets)
|
-8.42%
|
-4.9%
|
-13.7%
|
-8.16%
|
-6.59%
|
-4.6%
|
Assets
1 |
3,153
|
3,246
|
2,588
|
3,594
|
3,846
|
-4,516
|
Book Value Per Share
2 |
11.70
|
10.00
|
6.300
|
6.390
|
4.680
|
6.530
|
Cash Flow per Share
2 |
1.570
|
1.000
|
1.210
|
1.850
|
1.910
|
1.630
|
Capex
1 |
79.9
|
231
|
108
|
116
|
31.5
|
36.6
|
Capex / Sales
|
9.89%
|
18.66%
|
9.68%
|
12.87%
|
3.82%
|
4.33%
|
Announcement Date
|
30/04/19
|
30/04/20
|
29/04/21
|
29/04/22
|
02/05/23
|
30/04/24
|
|
1st Jan change
|
Capi.
|
---|
| +106.86% | 95.69M | | +13.38% | 100B | | +12.13% | 40.03B | | +0.16% | 18.83B | | -14.13% | 2.41B | | +4.89% | 1.76B | | +24.59% | 1.19B | | -34.19% | 765M | | -35.08% | 745M | | -6.50% | 676M |
Glasses, Spectacles & Contact Lenses
|